Tribavirin may be helpful

doi:10.1136/bmj.310.6986.1065a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Nicholas Hallam,
Trevor Edmunds

Consultant virologist Regional Virus Laboratory, City Hospital, Royal Infirmary of Edinburgh NHS Trust, Edinburgh EH10 5SB
Consultant paediatrician Royal Hospital for Sick Children, Edinburgh Sick Children's NHS Trust, Edinburgh EH9 1LF

EDITOR,—David Isaacs makes no mention of tribavirin in the management of bronchiolitis.1 Despite its limited efficacy, possible toxicity, and expense (three 6 g phials cost pounds sterling585) the synthetic nucleoside tribavirin is the only specific antiviral agent licensed for treatment of respiratory syncytial virus infection (the main cause of bronchiolitis) and merits further …